Medical devices, healthcare technology and the business of care
PMA approval · P260007

Autus Size-Adjustable Valve

Edwards Lifesciences, LLC · Decision date Oct 1, 2026

FDA DECISIONP260007

What did the FDA approve?

FDA records P260007 as an original PMA application. The recorded decision is approval, dated Oct 1, 2026.

FDA approval order statement

Approval for AUTUS Size-Adjustable Valve: The AUTUS valve is indicated for the management of pediatric patients weighing greater than or equal to 10 kg who require surgical pulmonary valve replacement for dysfunctional native or surgically-repaired right ventricular outflow tract (RVOT), as determined by echocardiography to meet the following criteria: (1) severe pulmonary stenosis (i.e., right ventricle (RV) to pulmonary artery (PA) peak instantaneous gradient greater than or equal to 60 mmHg); (2) greater than or equal to moderate pulmonary regurgitation; or (3) greater than or equal to moderate pulmonary stenosis (i.e., RV to PA peak instantaneous gradient greater than or equal to 40 mmHg) and greater than or equal to moderate pulmonary regurgitation.
Regulatory pathway
Original PMA
Clinical specialty
Cardiovascular
Decision date
Oct 1, 2026

FDA source record

Regulatory record facts

Identifier
P260007
Regulatory pathway
Premarket approval application
Product code
SJL
Decision code
APPR
Decision date
Oct 1, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Heart-valve, polymeric.

Product code
SJL
FDA device class
3

The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.

FDA decision timeline

  1. P260007 received

    Application receipt date recorded by FDA.

  2. P260007 · FDA decision

    APPR

Timeline entries are records held by MedtechLedger for P260007. View FDA’s full supplement list.

Related devices and submissions

Explore the linked device profile

No additional submissions with a verified PMA or product-code relationship are linked here.

Regulatory context

An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Edwards Lifesciences, LLC

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
One Edwards Way, Irvine, CA, 92614

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records